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RATIONALE: Lung dendritic cells (DCs) have been shown to accumulate in human
fibrotic lung disease, but little is known concerning a role for DCs in the pathogenesis
of fibrotic lung.
OBJECTIVES: To characterize lung DCs in an in vivo model of bleomycin-induced
pulmonary fibrosis in mice.
METHODS: We characterized the kinetics and activation of pulmonary DCs during
the course of bleomycin-induced lung injury by flow cytometry on lung single-cell
suspensions. We also characterized the lymphocytes accumulating in bleomycin lung
and the chemokines susceptible to favor the recruitment of immune cells.
MEASUREMENTS AND MAIN RESULTS: We show, for the first time, that increased
numbers of CD11c(+)/major histocompatibility complex class II(+) DCs, including
CD11b(hi) monocyte-derived inflammatory DCs, infiltrate the lung of treated animals
during the fibrotic phase of the response to bleomycin. These DCs are mature DCs
expressing CD40, CD86, and CD83. They are associated with increased numbers of
recently activated memory T cells expressing CD44, CD40L, and CD28, suggesting
that fully mature DCs and Ag-experienced T cells can drive an efficient effector
immune response within bleomycin lung. Most importantly, when DCs are inactivated
with VAG539, a recently described new immunomodulator, VAG539 treatment
attenuates the hallmarks of bleomycin lung injury.
CONCLUSIONS: These findings identify lung DCs as key proinflammatory cells
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